Document is current
Any future updates will be listed below
-
Authors
Siekierska, Aleksandra
Stamberger, Hannah
Deconinck, Tine
Oprescu, Stephanie N.
Partoens, Michèle
Zhang, Yifan
Sourbron, Jo
Adriaenssens, Elias
Mullen, Patrick
Wiencek, Patrick
Hardies, Katia
Lee, Jeong-Soo
Giong, Hoi-Khoanh
Distelmaier, Felix
Elpeleg, Orly
Helbig, Katherine L.
Hersh, Joseph
Isikay, Sedat
Jordan, Elizabeth
Karaca, Ender
Kecskes, Angela
Lupski, James R.
Kovacs-Nagy, Reka
May, Patrick https://orcid.org/0000-0001-8698-3770
Narayanan, Vinodh https://orcid.org/0000-0002-0658-3847
Pendziwiat, Manuela
Ramsey, Keri
Rangasamy, Sampathkumar
Shinde, Deepali N.
Spiegel, Ronen
Timmerman, Vincent
von Spiczak, Sarah
Helbig, Ingo
,
Balak, Chris
Belnap, Newell
Claasen, Ana
Courtright, Amanda
de Both, Matt
Huentelman, Matthew J.
Naymik, Marcus
Richholt, Ryan
Siniard, Ashley L.
Szelinger, Szabolcs
Craig, David W.
Schrauwen, Isabelle
,
Afawi, Zaid
Balling, Rudi
Baulac, Stéphanie
Barišić, Nina
Caglayan, Hande S.
Craiu, Dana
Guerrero-López, Rosa
Guerrini, Renzo
Hjalgrim, Helle
Jähn, Johanna
Klein, Karl Martin
Leguern, Eric
Lemke, Johannes R.
Lerche, Holger
Marini, Carla
Møller, Rikke S.
Muhle, Hiltrud
Rosenow, Felix
Serratosa, Jose
Suls, Arvid
Stephani, Ulrich
Štěrbová, Katalin
Striano, Pasquale
Zara, Federico
Weckhuysen, Sarah https://orcid.org/0000-0003-2878-1147
Francklyn, Christopher
Antonellis, Anthony
de Witte, Peter https://orcid.org/0000-0002-9989-9567
De Jonghe, Peter
- License Information
-
More Information
Article History
Received: 20 December 2017
Accepted: 3 October 2018
First Online: 12 February 2019
Competing interests
: J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., is on the Scientific Advisory Board of Baylor Genetic (BG) and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the BG Laboratories. All the remaining authors declare no competing interests.
